Zurich Cantonal Bank’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$476K Sell
26,751
-842
-3% -$15K ﹤0.01% 1700
2025
Q1
$492K Buy
27,593
+208
+0.8% +$3.71K ﹤0.01% 1609
2024
Q4
$816K Buy
27,385
+4,760
+21% +$142K ﹤0.01% 1314
2024
Q3
$354K Sell
22,625
-371
-2% -$5.8K ﹤0.01% 1771
2024
Q2
$394K Sell
22,996
-178
-0.8% -$3.05K ﹤0.01% 1648
2024
Q1
$362K Sell
23,174
-161
-0.7% -$2.52K ﹤0.01% 1680
2023
Q4
$348K Buy
23,335
+4,982
+27% +$74.4K ﹤0.01% 1743
2023
Q3
$296K Sell
18,353
-1,679
-8% -$27.1K ﹤0.01% 1712
2023
Q2
$831K Buy
20,032
+49
+0.2% +$2.03K ﹤0.01% 1037
2023
Q1
$1.2M Buy
19,983
+3,627
+22% +$218K 0.01% 829
2022
Q4
$1.2M Sell
16,356
-10
-0.1% -$734 0.01% 809
2022
Q3
$1.24M Sell
16,366
-43,053
-72% -$3.27M 0.01% 785
2022
Q2
$4.13M Sell
59,419
-17,448
-23% -$1.21M 0.02% 516
2022
Q1
$6.37M Buy
76,867
+42,770
+125% +$3.54M 0.03% 444
2021
Q4
$2.56M Buy
34,097
+3,592
+12% +$270K 0.01% 687
2021
Q3
$3.54M Buy
30,505
+5,249
+21% +$610K 0.02% 605
2021
Q2
$5.6M Buy
25,256
+5,146
+26% +$1.14M 0.03% 461
2021
Q1
$2.66M Buy
20,110
+5,714
+40% +$755K 0.02% 631
2020
Q4
$2.49M Buy
14,396
+4,380
+44% +$758K 0.02% 677
2020
Q3
$1.12M Buy
10,016
+574
+6% +$63.9K 0.01% 825
2020
Q2
$560K Buy
9,442
+2,980
+46% +$177K ﹤0.01% 966
2020
Q1
$435K Buy
6,462
+1,175
+22% +$79.1K ﹤0.01% 910
2019
Q4
$446K Buy
5,287
+474
+10% +$40K ﹤0.01% 959
2019
Q3
$360K Buy
4,813
+240
+5% +$18K ﹤0.01% 990
2019
Q2
$289K Buy
4,573
+546
+14% +$34.5K ﹤0.01% 1063
2019
Q1
$194K Buy
4,027
+188
+5% +$9.06K ﹤0.01% 1203
2018
Q4
$129K Hold
3,839
﹤0.01% 1441
2018
Q3
$201K Hold
3,839
﹤0.01% 1302
2018
Q2
$120K Buy
3,839
+1,040
+37% +$32.5K ﹤0.01% 1547
2018
Q1
$61K Hold
2,799
﹤0.01% 1923
2017
Q4
$57K Buy
2,799
+2,055
+276% +$41.8K ﹤0.01% 1966
2017
Q3
$15K Buy
+744
New +$15K ﹤0.01% 2346